Celularity Inc CELU

US Biotechnology

$1.37 ▼ -2.14% ($-0.03)

⬇️ Below Yest. Low 🎈 Low Float

Open $1.38

Prev Close $1.40

Day Range $1.33 – $1.40

52W Range $0.56 – $2.55

Market Cap $39.66M

Beta 0.87

EPS (TTM) $-3.59

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-05-23
Shares Out.	28,950,000
Website	celularity.com/ ↗
Phone	18009279800
Employees	115
Revenue	$4.1M
Gross Profit	-$3.3M
Net Income	-$24.4M
Free Cash Flow	-$13.3M
Total Assets	$107.3M
Total Liabilities	$145.4M
Equity	-$38.1M

About Celularity Inc

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Celularity Inc is a publicly traded company under the ticker symbol CELU on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.